Clinical Study

Mild to moderate Alzheimer's Disease (IM)

The Butler Hospital Memory & Aging Program is conducting a clinical research study of an intramuscularly-administered, investigational drug called ACC-01, a conjugate to a beta-amyloid protein.  This study tests whether the investigational drug ACC-01 safely provides clinical benefit to people with mild to moderate Alzheimer's disease (AD).

Qualified participants must be:

•  from 50 to 85 years of age
•  diagnosed with mild to moderate Alzheimer's disease
•  not taking Coumadin®
•  accompanied by a regular caregiver to 24 study visits over a 2-year period

For more information please call 401-455-6403.

All inquiries are confidential.